{
  "cells": [
    {
      "cell_type": "markdown",
      "source": [
        "# Bioequivalence\n\nBioequivalence.jl is a package for performing bioequivalence analysis part of the PumasAI ecosystem for pharmaceutical science (e.g. Pumas.jl: the simulation engine for PKPD, PBPK, QSP, and other models).\n\nThe documentation provides a how-to and technical details for performing bioequivalence analysis using various designs.\n\n## Setup\n\nUsing JuliaPro,\n\n### Installing\n\n```\nusing Pkg;\nPkg.add(\"Bioequivalence\")\n```\n\n### Loading\n\n```\nusing Bioequivalence\n```\n\n## API\n\n```\nBioequivalenceStudy(data::AbstractDataFrame,\n                    endpoint::Union{Integer, Symbol} = :AUC;\n                    id::Union{Integer, Symbol} = :id,\n                    sequence::Union{Integer, Symbol} = :sequence,\n                    period::Union{Integer, Symbol} = :period,\n                    reference::Union{Nothing, Char} = nothing,\n                    nonparametric::Bool = occursin(r\"(?i)tmax\", string(endpoint))),\n                    reml::Bool = false)\n```\n\nReturn a bioequivalence study\n\nArguments\n\n- data: must have id, sequence, period, and an endpoint.\n- id (e.g., 1)\n- sequence (e.g., RT which means first R and T in the second period)\n- period (e.g, 1:4)\n- endpoint: which variable is the endpoint?\n- id: which variable is the subject id?\n- sequence: which variable is the sequence?\n- period: which variable is the period?\n- reference: which formulation is the reference?\n\nFor example, in a design with RTTR|TRRT one can specify 'R' to be the reference. By default, the reference is taken to be the first character (alphabetically).\n\n- nonparametric: use nonparametric method for analysis of the endpoint?\n- reml: if the design uses a linear mixed model should it optimize REML instead of ML?\n\nEach bioequivalence study has the following fields:\n\n- data: data used for the study\n- design: number of subjects in each sequence\n- model: statistical models used for the analysis\n- result: result based on previous components\n\nCurrent designs include:\n- Parallel (e.g., R|T, A|B|C)\n- 2x2 (e.g., RT|TR)\n- Balaam (e.g., RR|RT|TR|TT)\n- Dual (e.g., RTT|TRR)\n- 2S4P1 (e.g., RTTR|TRRT)\n- 2S4P2 (e.g., RTRT|TRTR)\n- WD3F (e.g., ABC|ACB|BAC|BCA|CAB|CBA)\n- WD4F (e.g., ABCD|CADB|DCBA|BDAC)\n\n## Designs\n\n### Housekeeping\n\nLoading a few packages to showcase the features provided by `Bioequivalence`"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "using CSV, DataFrames, StatsBase, Bioequivalence"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Nonparametric\n\nNonparametric designs are included for analysis of endpoints such as Tmax."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ31 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/Nonparametric/PJ2006_3_1.tsv\"))\nfirst(PJ31, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The average bioequivalence analysis can be requested through `BioequivalenceStudy`"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Tmax = read_be(PJ31, :Tmax)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "When the name of the endpoint matches some form of Tmax (case insensitive) it defaults to nonparametric.\n\nOtherwise, it will attempt a parametric design. This can be overwriten through the `nonparametric` argument.\n\nNonparametric analysis uses the Wilcoxon signed rank test."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Tmax.model"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Other endpoints can potentially be analyzed through a nonparametric method as well"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ46 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/Williams/PJ2006_4_6.tsv\"))\nfirst(PJ46, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "NP = read_be(PJ46, nonparametric = true)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Parallel\n\nConsider a parallel design dataset with balance between treatment groups such as Clayton and Leslie ([1981](https://doi.org/10.1177/030006058100900608))."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "ClaytonandLeslie1981 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                                       \"/../data/Parallel/FSL2015_1.tsv\"))\nfirst(ClaytonandLeslie1981, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The bioequivalence analysis can be requested through `BioequivalenceStudy` or its alias `read_be`."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "# notice it defaults to the AUC endpoint\nParallel = read_be(ClaytonandLeslie1981)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The output shows the design, statistical model, and result.\n\nOne can access the statistical model directly through"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Parallel.model"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The results can be accessed through"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Parallel.result"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "or calling `coeftable` on the object"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "coeftable(Parallel)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Notice that the results are validated with those reported in Fuglsang, Schütz, and Labes ([2015](https://doi.org/10.1208/s12248-014-9704-6)). The Geometric Means Ratio (GMR) has a point estimate of (48.58) and a 90% confidence interval of (26.78, 88.14). These are the values reported in the study obtained with various statistical packages with the Welch correction.\n\n### Crossover\n\nThe most common bioequivalence design is perhaps the 2x2 crossover (RT|TR). Consider a dataset from Schütz, Labes, and Fuglsang ([2014](https://doi.org/10.1208/s12248-014-9661-0)) which has been simulated with an extreme range in raw data, outliers, and imbalance between sequences and a large number of subjects."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "SLF2014 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                          \"/../data/2S2P/SLF2014_8.tsv\"))\nfirst(SLF2014, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The bioequivalence analysis can be requested through `BioequivalenceStudy`"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "# notice it defaults to the AUC endpoint\nCrossover = read_be(SLF2014)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "As with other designs one can access the specific elements of the models use in the analysis."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "loglikelihood(Crossover.model.model)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The results are obtained through,"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Crossover.result"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Crossover 2x2 designs are validated with Schütz, Labes, and Fuglsang ([2014](https://doi.org/10.1208/s12248-014-9661-0)) and Patterson and Jones (2006). In this example, the estimate for the GMR is (93.42) with a 90% confidence interval of (86.81, 100.55).\n\n### Balaam\n\nThe Balaam design (RR|RT|TR|TT) is explored with a dataset from Chow and Liu (2009)."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "ChowandLiu2009 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                                 \"/../data/Balaam/CL2009_9_2_1.tsv\"))\nfirst(ChowandLiu2009, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "The data has the same specification as other crossover studies.\n\nThe analysis follows similarly as well."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "# notice it defaults to the AUC endpoint\nBalaam = read_be(ChowandLiu2009)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "We can also obtain the results for the intra-subject variabilities through"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Balaam.model.σ"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Designs with repeated measures include rescaled parameter estimates and variance analysis.\n\nThe rescaled parameter estimates are especially of interest when the reference drug is a highly variable drug (HVD) or a narrow therapeutic index (NTI) drug (Haidar et al. 2008).\n\nThe default values are:\n\n- regulatory constant for reference-scaled estimates: 0.1\n- auxiliary parameter for reference-scaled estimates: 1.11\n\nThese maybe be overwriten by passing the keyword arguments (see the docstring of `read_be` for more details).\n\n### Dual\n\nConsider the example 4.1 in Patterson and Jones (2006)"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ41 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/Dual/PJ2006_4_1.tsv\"))\nfirst(PJ41, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Dual = read_be(PJ41, :Cmax)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "### 2S4P Designs\n\nFor 2S4P designs both RRTT|TTRR and RTRT|TRTR are supported"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ43 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/2S4P/PJ2006_4_3.tsv\"))\nfirst(PJ43, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Inner = read_be(PJ43)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ44 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/2S4P/PJ2006_4_4.tsv\"))\nfirst(PJ44, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "Outer = read_be(PJ44, :Cmax)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "### Williams\n\nConsider a 3 formulations Williams design"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ45 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/Williams/PJ2006_4_5.tsv\"))\nfirst(PJ45, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "W3F = read_be(PJ45)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Imagine for a moment that the reference formulation is actually S instead of R.\nOne can pass such a parameter as following."
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "W3F = read_be(PJ45, reference = 'S')"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "Williams designs for four formulations are available as well"
      ],
      "metadata": {}
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "PJ46 = CSV.read(string(dirname(pathof(Bioequivalence)),\n                       \"/../data/Williams/PJ2006_4_6.tsv\"))\nfirst(PJ46, 6)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "outputs": [],
      "cell_type": "code",
      "source": [
        "W4F = read_be(PJ46)"
      ],
      "metadata": {},
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "## References\n\nChow, Shein-Chung, and Jen-pei Liu. 2009. Design and Analysis of Bioavailability and Bioequivalence Studies. 3rd ed. Chapman & Hall/CRC Biostatistics Series 27. Boca Raton: CRC Press.\n\nClayton, D, and A Leslie. 1981. \"The Bioavailability of Erythromycin Stearate versus Enteric-Coated Erythromycin Base When Taken Immediately before and after Food.\" Journal of International Medical Research 9 (6): 470-77. [DOI:10.1177/030006058100900608](https://doi.org/10.1177/030006058100900608).\n\nFuglsang, Anders, Helmut Schütz, and Detlew Labes. 2015. \"Reference Datasets for Bioequivalence Trials in a Two-Group Parallel Design.\" The AAPS Journal 17 (2): 400-404. [DOI:10.1208/s12248-014-9704-6](https://doi.org/10.1208/s12248-014-9704-6).\n\nHaidar, Sam H., Fairouz Makhlouf, Donald J. Schuirmann, Terry Hyslop, Barbara Davit, Dale Conner, and Lawrence X. Yu. 2008. \"Evaluation of a Scaling Approach for the Bioequivalence of Highly Variable Drugs.\" The AAPS Journal 10 (3): 450-54. [DOI:10.1208/s12248-008-9053-4](https://doi.org/10.1208/s12248-008-9053-4).\n\nPatterson, Scott D, and Byron Jones. 2006. Bioequivalence and Statistics in Clinical Pharmacology. Boca Raton: Chapman & Hall/CRC. ISBN: 9781420034936.\n\nSchütz, Helmut, Detlew Labes, and Anders Fuglsang. 2014. \"Reference Datasets for 2-Treatment, 2-Sequence, 2-Period Bioequivalence Studies.\" The AAPS Journal 16 (6): 1292-97. [DOI:10.1208/s12248-014-9661-0](https://doi.org/10.1208/s12248-014-9661-0)."
      ],
      "metadata": {}
    }
  ],
  "nbformat_minor": 2,
  "metadata": {
    "language_info": {
      "file_extension": ".jl",
      "mimetype": "application/julia",
      "name": "julia",
      "version": "1.2.0"
    },
    "kernelspec": {
      "name": "julia-1.2",
      "display_name": "Julia 1.2.0",
      "language": "julia"
    }
  },
  "nbformat": 4
}
